| 1 | enrolled | 20,904 |
| 2 | enroled | 43 |
| 3 | co-enrolled | 10 |
| 4 | person/years | 7 |
| 5 | p16ink4a-positive | 4 |
| 6 | recuited | 4 |
| 7 | 005/actg | 2 |
| 8 | 1.462 | 2 |
| 9 | districted | 2 |
| 10 | dizziness/vertigo | 2 |
| 11 | e4a03 | 2 |
| 12 | investgated | 2 |
| 13 | isoverbascoside | 2 |
| 14 | micro-costed | 2 |
| 15 | non-different | 2 |
| 16 | nongoitrous | 2 |
| 17 | p42.3-positive | 2 |
| 18 | post-fixed | 2 |
| 19 | re-trained | 2 |
| 20 | retrospected | 2 |
| 21 | si5o10 | 2 |
| 22 | sub-transplanted | 2 |
| 23 | -0.02m/s | 1 |
| 24 | -10.20mg/dl | 1 |
| 25 | -6.2°±10° | 1 |
| 26 | -8.7±12.2 | 1 |
| 27 | 0,98 | 1 |
| 28 | 0.06-500μgl | 1 |
| 29 | 0.0867 | 1 |
| 30 | 0.0903 | 1 |
| 31 | 0.108l | 1 |
| 32 | 0.12±0.01cm | 1 |
| 33 | 0.21-12µg/ml | 1 |
| 34 | 0.34+/-0.54 | 1 |
| 35 | 0.46l | 1 |
| 36 | 0.77×10 | 1 |
| 37 | 0.81/0.19 | 1 |
| 38 | 0/382 | 1 |
| 39 | 0·397 | 1 |
| 40 | 1,284/15,142 | 1 |
| 41 | 1,501.31 | 1 |
| 42 | 1.11494 | 1 |
| 43 | 1.54°c | 1 |
| 44 | 1.5db | 1 |
| 45 | 1.5±1.1h | 1 |
| 46 | 1.5μm | 1 |
| 47 | 1.69-12.61 | 1 |
| 48 | 11.754 | 1 |
| 49 | 111/956 | 1 |
| 50 | 112.6±19.2 | 1 |
| 51 | 116.42 | 1 |
| 52 | 1211.66±14.29 | 1 |
| 53 | 14.1±3.0 | 1 |
| 54 | 147pm | 1 |
| 55 | 15.3h | 1 |
| 56 | 15.73±10.67 | 1 |
| 57 | 15.8h | 1 |
| 58 | 16.4/1000 | 1 |
| 59 | 16.5±10.5 | 1 |
| 60 | 160/472 | 1 |
| 61 | 164/285 | 1 |
| 62 | 17.4±2.8db | 1 |
| 63 | 17547 | 1 |
| 64 | 1·64±0·70x10 | 1 |
| 65 | 2.10±0.97 | 1 |
| 66 | 2.29-3.32 | 1 |
| 67 | 2.392 | 1 |
| 68 | 2.65logiu/ml | 1 |
| 69 | 26-32°c | 1 |
| 70 | 294/351 | 1 |
| 71 | 3.2-3.6 | 1 |
| 72 | 31.47℃ | 1 |
| 73 | 31/139 | 1 |
| 74 | 34.23 | 1 |
| 75 | 351/550 | 1 |
| 76 | 37/87 | 1 |
| 77 | 38.7±9.358 | 1 |
| 78 | 382.41 | 1 |
| 79 | 45,615 | 1 |
| 80 | 48±4nm | 1 |
| 81 | 49,475 | 1 |
| 82 | 5.03×10 | 1 |
| 83 | 5.78-9.37 | 1 |
| 84 | 520/539 | 1 |
| 85 | 56.0+/-14.4 | 1 |
| 86 | 56/89 | 1 |
| 87 | 560.0 | 1 |
| 88 | 59/251 | 1 |
| 89 | 6,996 | 1 |
| 90 | 6/210 | 1 |
| 91 | 61.1°c | 1 |
| 92 | 61.7±8.1 | 1 |
| 93 | 62patients | 1 |
| 94 | 672,117 | 1 |
| 95 | 685.65 | 1 |
| 96 | 7.27±0.19 | 1 |
| 97 | 7.55±2.00 | 1 |
| 98 | 7.584 | 1 |
| 99 | 7352 | 1 |
| 100 | 7503 | 1 |
| 101 | 8.13mg | 1 |
| 102 | 8.1±8.4 | 1 |
| 103 | 8470 | 1 |
| 104 | 89/1169 | 1 |
| 105 | 9.3±15.7weeks | 1 |
| 106 | 9041.4 | 1 |
| 107 | 97/291 | 1 |
| 108 | 98/116 | 1 |
| 109 | accummulated | 1 |
| 110 | ace-i-intolerant | 1 |
| 111 | antianemics | 1 |
| 112 | assessed-82 | 1 |
| 113 | assessed.each | 1 |
| 114 | aud57 | 1 |
| 115 | autotrasplanted | 1 |
| 116 | calycosin-7-o-β-d-glucopyranoside | 1 |
| 117 | caryophylladienol-ii | 1 |
| 118 | celts | 1 |
| 119 | clean/debrided | 1 |
| 120 | cmi-positive | 1 |
| 121 | co-cultured/co-implanted | 1 |
| 122 | co-overproduced | 1 |
| 123 | cold-boned | 1 |
| 124 | colonoscoped | 1 |
| 125 | conductes | 1 |
| 126 | cross-used | 1 |
| 127 | culturenegative | 1 |
| 128 | curtured | 1 |
| 129 | detetectable | 1 |
| 130 | diagnosed-four | 1 |
| 131 | divergers | 1 |
| 132 | don-upregulated | 1 |
| 133 | enchased | 1 |
| 134 | euro6767 | 1 |
| 135 | evaulated | 1 |
| 136 | haemorragia | 1 |
| 137 | hyper-induced | 1 |
| 138 | impugned | 1 |
| 139 | in-effective | 1 |
| 140 | includec | 1 |
| 141 | incresed | 1 |
| 142 | inter-esterified | 1 |
| 143 | inupiat | 1 |
| 144 | malaise/lassitude | 1 |
| 145 | milimetric | 1 |
| 146 | misdemeanors | 1 |
| 147 | mount-ed | 1 |
| 148 | negative/reactive | 1 |
| 149 | non-detected | 1 |
| 150 | nonreactogenic | 1 |
| 151 | numbness/hypoesthesia | 1 |
| 152 | only/oldest | 1 |
| 153 | over-turned | 1 |
| 154 | overadherent | 1 |
| 155 | overhauled | 1 |
| 156 | p.f508del | 1 |
| 157 | pain/tenderness/discomfort | 1 |
| 158 | paramenopausal | 1 |
| 159 | pominent | 1 |
| 160 | postfixed | 1 |
| 161 | pre-enriched | 1 |
| 162 | preclampsia | 1 |
| 163 | preservable | 1 |
| 164 | presodded | 1 |
| 165 | pressure/stiffness | 1 |
| 166 | quinoxaline-1,4-dioxide | 1 |
| 167 | r-b6 | 1 |
| 168 | randomlyassigned | 1 |
| 169 | rare-0 | 1 |
| 170 | re-detected | 1 |
| 171 | re-inserted | 1 |
| 172 | received-recently | 1 |
| 173 | recorded.differences | 1 |
| 174 | reported-herbalism | 1 |
| 175 | rhinitis/tonsillitis/pharyngitis | 1 |
| 176 | rituxan-refractory | 1 |
| 177 | rs1805126 | 1 |
| 178 | sadder | 1 |
| 179 | satisfacoty | 1 |
| 180 | segmentectomy/metastectomy | 1 |
| 181 | self-respondents | 1 |
| 182 | smokers,19 | 1 |
| 183 | soft-relined | 1 |
| 184 | subspherical | 1 |
| 185 | sulfamethoxazole-susceptible | 1 |
| 186 | t/b-lymphocytes | 1 |
| 187 | ticrmezrctxr | 1 |
| 188 | trans-thujone | 1 |
| 189 | tricholomataceae | 1 |
| 190 | un-displaced | 1 |
| 191 | uncontradicted | 1 |
| 192 | under-adherent | 1 |
| 193 | under-populated | 1 |
| 194 | underadherent | 1 |
| 195 | underweight-for-age | 1 |
| 196 | upward-titrated | 1 |
| 197 | used.wp1066 | 1 |
| 198 | uti-131 | 1 |
| 199 | €1,189 | 1 |
| 200 | €13 | 1 |
| 201 | €18,201 | 1 |
| 202 | €2,061 | 1 |
| 203 | €361 | 1 |
| 204 | €37,195 | 1 |
| 205 | €4795 | 1 |
| 206 | €5387 | 1 |
| 207 | €7,179 | 1 |
| 208 | €774 | 1 |
| 209 | €9 | 1 |
| 210 | €9977 | 1 |
| 211 | ≥45° | 1 |
| 1 | -0.02m/s | 1 |
| 2 | -10.20mg/dl | 1 |
| 3 | -6.2°±10° | 1 |
| 4 | -8.7±12.2 | 1 |
| 5 | 0,98 | 1 |
| 6 | 0.06-500μgl | 1 |
| 7 | 0.0867 | 1 |
| 8 | 0.0903 | 1 |
| 9 | 0.108l | 1 |
| 10 | 0.12±0.01cm | 1 |
| 11 | 0.21-12µg/ml | 1 |
| 12 | 0.34+/-0.54 | 1 |
| 13 | 0.46l | 1 |
| 14 | 0.77×10 | 1 |
| 15 | 0.81/0.19 | 1 |
| 16 | 0/382 | 1 |
| 17 | 005/actg | 2 |
| 18 | 0·397 | 1 |
| 19 | 1,284/15,142 | 1 |
| 20 | 1,501.31 | 1 |
| 21 | 1.11494 | 1 |
| 22 | 1.462 | 2 |
| 23 | 1.54°c | 1 |
| 24 | 1.5db | 1 |
| 25 | 1.5±1.1h | 1 |
| 26 | 1.5μm | 1 |
| 27 | 1.69-12.61 | 1 |
| 28 | 11.754 | 1 |
| 29 | 111/956 | 1 |
| 30 | 112.6±19.2 | 1 |
| 31 | 116.42 | 1 |
| 32 | 1211.66±14.29 | 1 |
| 33 | 14.1±3.0 | 1 |
| 34 | 147pm | 1 |
| 35 | 15.3h | 1 |
| 36 | 15.73±10.67 | 1 |
| 37 | 15.8h | 1 |
| 38 | 16.4/1000 | 1 |
| 39 | 16.5±10.5 | 1 |
| 40 | 160/472 | 1 |
| 41 | 164/285 | 1 |
| 42 | 17.4±2.8db | 1 |
| 43 | 17547 | 1 |
| 44 | 1·64±0·70x10 | 1 |
| 45 | 2.10±0.97 | 1 |
| 46 | 2.29-3.32 | 1 |
| 47 | 2.392 | 1 |
| 48 | 2.65logiu/ml | 1 |
| 49 | 26-32°c | 1 |
| 50 | 294/351 | 1 |
| 51 | 3.2-3.6 | 1 |
| 52 | 31.47℃ | 1 |
| 53 | 31/139 | 1 |
| 54 | 34.23 | 1 |
| 55 | 351/550 | 1 |
| 56 | 37/87 | 1 |
| 57 | 38.7±9.358 | 1 |
| 58 | 382.41 | 1 |
| 59 | 45,615 | 1 |
| 60 | 48±4nm | 1 |
| 61 | 49,475 | 1 |
| 62 | 5.03×10 | 1 |
| 63 | 5.78-9.37 | 1 |
| 64 | 520/539 | 1 |
| 65 | 56.0+/-14.4 | 1 |
| 66 | 56/89 | 1 |
| 67 | 560.0 | 1 |
| 68 | 59/251 | 1 |
| 69 | 6,996 | 1 |
| 70 | 6/210 | 1 |
| 71 | 61.1°c | 1 |
| 72 | 61.7±8.1 | 1 |
| 73 | 62patients | 1 |
| 74 | 672,117 | 1 |
| 75 | 685.65 | 1 |
| 76 | 7.27±0.19 | 1 |
| 77 | 7.55±2.00 | 1 |
| 78 | 7.584 | 1 |
| 79 | 7352 | 1 |
| 80 | 7503 | 1 |
| 81 | 8.13mg | 1 |
| 82 | 8.1±8.4 | 1 |
| 83 | 8470 | 1 |
| 84 | 89/1169 | 1 |
| 85 | 9.3±15.7weeks | 1 |
| 86 | 9041.4 | 1 |
| 87 | 97/291 | 1 |
| 88 | 98/116 | 1 |
| 89 | accummulated | 1 |
| 90 | ace-i-intolerant | 1 |
| 91 | antianemics | 1 |
| 92 | assessed-82 | 1 |
| 93 | assessed.each | 1 |
| 94 | aud57 | 1 |
| 95 | autotrasplanted | 1 |
| 96 | calycosin-7-o-β-d-glucopyranoside | 1 |
| 97 | caryophylladienol-ii | 1 |
| 98 | celts | 1 |
| 99 | clean/debrided | 1 |
| 100 | cmi-positive | 1 |
| 101 | co-cultured/co-implanted | 1 |
| 102 | co-enrolled | 10 |
| 103 | co-overproduced | 1 |
| 104 | cold-boned | 1 |
| 105 | colonoscoped | 1 |
| 106 | conductes | 1 |
| 107 | cross-used | 1 |
| 108 | culturenegative | 1 |
| 109 | curtured | 1 |
| 110 | detetectable | 1 |
| 111 | diagnosed-four | 1 |
| 112 | districted | 2 |
| 113 | divergers | 1 |
| 114 | dizziness/vertigo | 2 |
| 115 | don-upregulated | 1 |
| 116 | e4a03 | 2 |
| 117 | enchased | 1 |
| 118 | enroled | 43 |
| 119 | enrolled | 20,904 |
| 120 | euro6767 | 1 |
| 121 | evaulated | 1 |
| 122 | haemorragia | 1 |
| 123 | hyper-induced | 1 |
| 124 | impugned | 1 |
| 125 | in-effective | 1 |
| 126 | includec | 1 |
| 127 | incresed | 1 |
| 128 | inter-esterified | 1 |
| 129 | inupiat | 1 |
| 130 | investgated | 2 |
| 131 | isoverbascoside | 2 |
| 132 | malaise/lassitude | 1 |
| 133 | micro-costed | 2 |
| 134 | milimetric | 1 |
| 135 | misdemeanors | 1 |
| 136 | mount-ed | 1 |
| 137 | negative/reactive | 1 |
| 138 | non-detected | 1 |
| 139 | non-different | 2 |
| 140 | nongoitrous | 2 |
| 141 | nonreactogenic | 1 |
| 142 | numbness/hypoesthesia | 1 |
| 143 | only/oldest | 1 |
| 144 | over-turned | 1 |
| 145 | overadherent | 1 |
| 146 | overhauled | 1 |
| 147 | p.f508del | 1 |
| 148 | p16ink4a-positive | 4 |
| 149 | p42.3-positive | 2 |
| 150 | pain/tenderness/discomfort | 1 |
| 151 | paramenopausal | 1 |
| 152 | person/years | 7 |
| 153 | pominent | 1 |
| 154 | post-fixed | 2 |
| 155 | postfixed | 1 |
| 156 | pre-enriched | 1 |
| 157 | preclampsia | 1 |
| 158 | preservable | 1 |
| 159 | presodded | 1 |
| 160 | pressure/stiffness | 1 |
| 161 | quinoxaline-1,4-dioxide | 1 |
| 162 | r-b6 | 1 |
| 163 | randomlyassigned | 1 |
| 164 | rare-0 | 1 |
| 165 | re-detected | 1 |
| 166 | re-inserted | 1 |
| 167 | re-trained | 2 |
| 168 | received-recently | 1 |
| 169 | recorded.differences | 1 |
| 170 | recuited | 4 |
| 171 | reported-herbalism | 1 |
| 172 | retrospected | 2 |
| 173 | rhinitis/tonsillitis/pharyngitis | 1 |
| 174 | rituxan-refractory | 1 |
| 175 | rs1805126 | 1 |
| 176 | sadder | 1 |
| 177 | satisfacoty | 1 |
| 178 | segmentectomy/metastectomy | 1 |
| 179 | self-respondents | 1 |
| 180 | si5o10 | 2 |
| 181 | smokers,19 | 1 |
| 182 | soft-relined | 1 |
| 183 | sub-transplanted | 2 |
| 184 | subspherical | 1 |
| 185 | sulfamethoxazole-susceptible | 1 |
| 186 | t/b-lymphocytes | 1 |
| 187 | ticrmezrctxr | 1 |
| 188 | trans-thujone | 1 |
| 189 | tricholomataceae | 1 |
| 190 | un-displaced | 1 |
| 191 | uncontradicted | 1 |
| 192 | under-adherent | 1 |
| 193 | under-populated | 1 |
| 194 | underadherent | 1 |
| 195 | underweight-for-age | 1 |
| 196 | upward-titrated | 1 |
| 197 | used.wp1066 | 1 |
| 198 | uti-131 | 1 |
| 199 | €1,189 | 1 |
| 200 | €13 | 1 |
| 201 | €18,201 | 1 |
| 202 | €2,061 | 1 |
| 203 | €361 | 1 |
| 204 | €37,195 | 1 |
| 205 | €4795 | 1 |
| 206 | €5387 | 1 |
| 207 | €7,179 | 1 |
| 208 | €774 | 1 |
| 209 | €9 | 1 |
| 210 | €9977 | 1 |
| 211 | ≥45° | 1 |
| 1 | rare-0 | 1 |
| 2 | 560.0 | 1 |
| 3 | 14.1±3.0 | 1 |
| 4 | 7.55±2.00 | 1 |
| 5 | 16.4/1000 | 1 |
| 6 | 6/210 | 1 |
| 7 | si5o10 | 2 |
| 8 | 1·64±0·70x10 | 1 |
| 9 | 5.03×10 | 1 |
| 10 | 0.77×10 | 1 |
| 11 | 351/550 | 1 |
| 12 | 8470 | 1 |
| 13 | 61.7±8.1 | 1 |
| 14 | €18,201 | 1 |
| 15 | 1,501.31 | 1 |
| 16 | uti-131 | 1 |
| 17 | 382.41 | 1 |
| 18 | 59/251 | 1 |
| 19 | 294/351 | 1 |
| 20 | 1.69-12.61 | 1 |
| 21 | €2,061 | 1 |
| 22 | €361 | 1 |
| 23 | 97/291 | 1 |
| 24 | -8.7±12.2 | 1 |
| 25 | 112.6±19.2 | 1 |
| 26 | 2.29-3.32 | 1 |
| 27 | 116.42 | 1 |
| 28 | 1,284/15,142 | 1 |
| 29 | 7352 | 1 |
| 30 | 1.462 | 2 |
| 31 | 160/472 | 1 |
| 32 | assessed-82 | 1 |
| 33 | 0/382 | 1 |
| 34 | 2.392 | 1 |
| 35 | 7503 | 1 |
| 36 | 0.0903 | 1 |
| 37 | e4a03 | 2 |
| 38 | €13 | 1 |
| 39 | 34.23 | 1 |
| 40 | 9041.4 | 1 |
| 41 | 56.0+/-14.4 | 1 |
| 42 | 8.1±8.4 | 1 |
| 43 | 0.34+/-0.54 | 1 |
| 44 | 11.754 | 1 |
| 45 | €774 | 1 |
| 46 | 7.584 | 1 |
| 47 | 1.11494 | 1 |
| 48 | 16.5±10.5 | 1 |
| 49 | 45,615 | 1 |
| 50 | 685.65 | 1 |
| 51 | 49,475 | 1 |
| 52 | 164/285 | 1 |
| 53 | €37,195 | 1 |
| 54 | €4795 | 1 |
| 55 | 3.2-3.6 | 1 |
| 56 | 98/116 | 1 |
| 57 | rs1805126 | 1 |
| 58 | 111/956 | 1 |
| 59 | used.wp1066 | 1 |
| 60 | 6,996 | 1 |
| 61 | r-b6 | 1 |
| 62 | 672,117 | 1 |
| 63 | 5.78-9.37 | 1 |
| 64 | 17547 | 1 |
| 65 | aud57 | 1 |
| 66 | 15.73±10.67 | 1 |
| 67 | euro6767 | 1 |
| 68 | 0.0867 | 1 |
| 69 | €9977 | 1 |
| 70 | 37/87 | 1 |
| 71 | €5387 | 1 |
| 72 | 2.10±0.97 | 1 |
| 73 | 0·397 | 1 |
| 74 | 38.7±9.358 | 1 |
| 75 | 0,98 | 1 |
| 76 | smokers,19 | 1 |
| 77 | 0.81/0.19 | 1 |
| 78 | 7.27±0.19 | 1 |
| 79 | 1211.66±14.29 | 1 |
| 80 | 31/139 | 1 |
| 81 | 520/539 | 1 |
| 82 | 89/1169 | 1 |
| 83 | €7,179 | 1 |
| 84 | 56/89 | 1 |
| 85 | €1,189 | 1 |
| 86 | €9 | 1 |
| 87 | haemorragia | 1 |
| 88 | numbness/hypoesthesia | 1 |
| 89 | preclampsia | 1 |
| 90 | 1.5db | 1 |
| 91 | 17.4±2.8db | 1 |
| 92 | includec | 1 |
| 93 | nonreactogenic | 1 |
| 94 | milimetric | 1 |
| 95 | 61.1°c | 1 |
| 96 | 26-32°c | 1 |
| 97 | 1.54°c | 1 |
| 98 | mount-ed | 1 |
| 99 | un-displaced | 1 |
| 100 | hyper-induced | 1 |
| 101 | co-overproduced | 1 |
| 102 | presodded | 1 |
| 103 | clean/debrided | 1 |
| 104 | pre-enriched | 1 |
| 105 | inter-esterified | 1 |
| 106 | enrolled | 20,904 |
| 107 | co-enrolled | 10 |
| 108 | enroled | 43 |
| 109 | overhauled | 1 |
| 110 | randomlyassigned | 1 |
| 111 | impugned | 1 |
| 112 | re-trained | 2 |
| 113 | soft-relined | 1 |
| 114 | cold-boned | 1 |
| 115 | over-turned | 1 |
| 116 | colonoscoped | 1 |
| 117 | curtured | 1 |
| 118 | enchased | 1 |
| 119 | incresed | 1 |
| 120 | cross-used | 1 |
| 121 | investgated | 2 |
| 122 | evaulated | 1 |
| 123 | don-upregulated | 1 |
| 124 | accummulated | 1 |
| 125 | under-populated | 1 |
| 126 | upward-titrated | 1 |
| 127 | retrospected | 2 |
| 128 | re-detected | 1 |
| 129 | non-detected | 1 |
| 130 | uncontradicted | 1 |
| 131 | districted | 2 |
| 132 | recuited | 4 |
| 133 | co-cultured/co-implanted | 1 |
| 134 | autotrasplanted | 1 |
| 135 | sub-transplanted | 2 |
| 136 | re-inserted | 1 |
| 137 | micro-costed | 2 |
| 138 | post-fixed | 2 |
| 139 | postfixed | 1 |
| 140 | tricholomataceae | 1 |
| 141 | isoverbascoside | 2 |
| 142 | calycosin-7-o-β-d-glucopyranoside | 1 |
| 143 | quinoxaline-1,4-dioxide | 1 |
| 144 | malaise/lassitude | 1 |
| 145 | underweight-for-age | 1 |
| 146 | detetectable | 1 |
| 147 | preservable | 1 |
| 148 | sulfamethoxazole-susceptible | 1 |
| 149 | trans-thujone | 1 |
| 150 | culturenegative | 1 |
| 151 | negative/reactive | 1 |
| 152 | in-effective | 1 |
| 153 | p42.3-positive | 2 |
| 154 | p16ink4a-positive | 4 |
| 155 | cmi-positive | 1 |
| 156 | 8.13mg | 1 |
| 157 | 005/actg | 2 |
| 158 | 1.5±1.1h | 1 |
| 159 | 15.3h | 1 |
| 160 | 15.8h | 1 |
| 161 | assessed.each | 1 |
| 162 | caryophylladienol-ii | 1 |
| 163 | 0.46l | 1 |
| 164 | 0.108l | 1 |
| 165 | subspherical | 1 |
| 166 | paramenopausal | 1 |
| 167 | -10.20mg/dl | 1 |
| 168 | p.f508del | 1 |
| 169 | 0.06-500μgl | 1 |
| 170 | 0.21-12µg/ml | 1 |
| 171 | 2.65logiu/ml | 1 |
| 172 | 0.12±0.01cm | 1 |
| 173 | 48±4nm | 1 |
| 174 | 147pm | 1 |
| 175 | reported-herbalism | 1 |
| 176 | 1.5μm | 1 |
| 177 | dizziness/vertigo | 2 |
| 178 | sadder | 1 |
| 179 | diagnosed-four | 1 |
| 180 | ticrmezrctxr | 1 |
| 181 | -0.02m/s | 1 |
| 182 | antianemics | 1 |
| 183 | recorded.differences | 1 |
| 184 | conductes | 1 |
| 185 | t/b-lymphocytes | 1 |
| 186 | rhinitis/tonsillitis/pharyngitis | 1 |
| 187 | 9.3±15.7weeks | 1 |
| 188 | person/years | 7 |
| 189 | divergers | 1 |
| 190 | misdemeanors | 1 |
| 191 | pressure/stiffness | 1 |
| 192 | celts | 1 |
| 193 | self-respondents | 1 |
| 194 | 62patients | 1 |
| 195 | nongoitrous | 2 |
| 196 | inupiat | 1 |
| 197 | ace-i-intolerant | 1 |
| 198 | pominent | 1 |
| 199 | non-different | 2 |
| 200 | under-adherent | 1 |
| 201 | underadherent | 1 |
| 202 | overadherent | 1 |
| 203 | pain/tenderness/discomfort | 1 |
| 204 | only/oldest | 1 |
| 205 | received-recently | 1 |
| 206 | segmentectomy/metastectomy | 1 |
| 207 | rituxan-refractory | 1 |
| 208 | satisfacoty | 1 |
| 209 | 31.47℃ | 1 |
| 210 | -6.2°±10° | 1 |
| 211 | ≥45° | 1 |